Breast cancer recurrence remains low, even after ten years, with radiotherapy tailored to patient’s individual risk
Barcelona, Spain: The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their individual risk following chemotherapy and surgery. These are the findings of a ten-year study presented at the 15th European Breast Cancer Conference (EBCC15) in Barcelona today (Wednesday).
In the study, radiotherapy treatment was selected according to whether there were still signs of breast cancer cells in patients’ lymph nodes after chemotherapy and surgery. For women with no signs of cancer remaining in the lymph nodes, this approach meant minimal or even no radiotherapy. Scaling treatment ...














